| |
ASM/ICAAC: Darunavir and Cobicistat in Older HIV-1-Infected Patients in a 48-week Phase 3 Trial
|
| |
| |
Reported by jules Levin
ASM/ICAAC 2016 June 16-20 Boston, MA
Brown K,1 Patterson B,1 Liu C,2 Patel M,1 Stewart L,1 Nettles RE1
1. Janssen Scientific Affairs, LLC, Titusville, NJ, US;
2. Janssen Research & Development, Titusville, NJ, US
|
|
| |
| |
|
|
|
